Skip to content

Low-Salt Diet Effect on Th17-Mediated Inflammation and Vascular Reactivity in Psoriasis

Effects of Low Salt Dietary Intake on Th17-Mediated Inflammation and Vascular Reactivity in Patients With Psoriasis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05892640
Enrollment
50
Registered
2023-06-07
Start date
2022-09-01
Completion date
2024-06-30
Last updated
2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis Vulgaris

Keywords

Diet, Sodium-Restricted, Psoriasis, Laser-Doppler Flowmetry, Microcirculation, Endothelium

Brief summary

Psoriasis presents an independent cardiovascular risk factor characterized by chronic low-grade systemic inflammation and oxidative stress which altogether might lead to endothelial dysfunction. It has been reported that increased oxidative stress has a pivotal role in high dietary sodium-induced endothelial dysfunction. Previous studies on sodium accumulation in psoriatic skin lesions and the sodium-induced augmentation in Th17 immune response, raise the question on the complex interplay between sodium and psoriasis, especially in the context of cardiovascular morbidity. This study aimed to investigate the effect of a 2-week low-salt diet on endothelium-dependent and endothelium-independent cutaneous microvascular vasodilation and Th17-Mediated Inflammation in patients with psoriasis vulgaris.

Interventions

Low-salt diet (LS diet) according to DASH eating plan, with sodium intake of 1500 mg (3.75 g of salt), within the period of 14 days

Sponsors

Josip Juraj Strossmayer University of Osijek
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* patients with diagnosed psoriasis vulgaris * subjects do not use topical corticosteroid therapy for at least 2 weeks before inclusion in the study and 2 weeks during the study * subjects do not use systemic or biological therapy for at least 3 months before and 2 weeks during the study.

Exclusion criteria

* age \< 18 years * existence of other immune-mediated diseases (with the exception of autoimmune thyroid diseases and psoriatic arthritis - people with these comorbidities can be included) * malignant diseases * current infectious diseases and allergic reactions within 6 weeks before the start of the study

Design outcomes

Primary

MeasureTime frameDescription
Microvascular endothelial function2 weeksCutaneous microvascular blood flow will be measured by Laser Doppler Flowmetry in response to vascular occlusion (post occlusive reactive hyperaemia - PORH), in response to iontophoresis of acetylcholine (ACh) and local thermal hyperemia (LTH) before and after LS diet protocol
Frequency of peripheral T helper 17 (Th17) and regulatory lymphocytes (Treg) among parent lymphocytes sub-population2 weeksFlow cytometry assessment of the frequencies of peripheral Treg and Th17 lymphocytes before and after LS diet protocol

Secondary

MeasureTime frameDescription
Microvascular non-endothelial function2 weeksCutaneous microvascular blood flow will be measured by Laser Doppler Flowmetry in response to iontophoresis of sodium nitroprusside (SNP) before and after LS diet protocol
Relative amount of serum- and glucocorticoid-induced kinase 1 (SGK1) in peripheral blood mononuclear cells2 weeksRelative amount of total serum- and glucocorticoid regulated kinase 1 (SGK1) in cultured cells will be measured by commercially available cell-based enzyme-linked immuno-sorbent assay (ELISA) kit before and after LS diet protocol
Serum Protein Concentration of Pro- and Anti-Inflammatory Cytokines2 weeksSerum protein concentrations (pg/mL) of pro-inflammatory and anti-inflammatory cytokines will be measured with panel for multiplex protein quantitation before and after LS diet protocol
24-hour natriuresis2 weeksA 24-h urinary sodium excretion will be measured in each participant before and after LS diet protocol in order to assess compliance to the given dietary protocol

Countries

Croatia

Contacts

Primary ContactInes Drenjančević, MD, PhD
ines.drenjancevic@mefos.hr+38531512800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026